INO Stock Price Chart
INO Earnings
Inovio Pharmaceuticals Inc
$1.35
1.5%
$0.02
At close: May 22, 16:00:00 GMT-4
$1.33
-1.48%
$-0.02
Post-market: May 22, 20:00:00 GMT-4
Back
Inovio Pharmaceuticals Inc (INO) Earnings
Key Stats
Prev.Close
$1.33
Open
$1.32
Day's Range
$1.32 - $1.45
52 week range
$1.03 - $2.97
Volume
3.2M
Avg.Volume
1.9M
Dividend yield
--
EPS (TTM)
-1.93
Market Cap
$108.3M
What is INO?
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 134 full-time employees. Its proprietary investigational CELLECTRA devices are designed to deliver the plasmids into the body’s cells for optimal effect, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. Its lead candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease caused by HPV-6 and HPV-11. Its DNA medicines in the pipeline include INO-3112 for the Treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, VGX-3100 for the Treatment of HPV-related Cervical HSIL, VGX-3100 for the Treatment of Anal or Perianal HSIL, INO-5401 for the Treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Prevention of Cancer for People with BRCA1/2 Mutation.
